4//SEC Filing
Weitzman Aaron 4
Accession 0000899243-22-037607
CIK 0001819133other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:10 PM ET
Size
5.5 KB
Accession
0000899243-22-037607
Insider Transaction Report
Form 4
Weitzman Aaron
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-12-01+350,000→ 350,000 totalExercise: $7.73Exp: 2032-12-01→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a four-year period, at a rate of 25% on December 1, 2023, with the remaining option shares vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Tango Therapeutics, Inc.
CIK 0001819133
Entity typeother
Related Parties
1- filerCIK 0001952088
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 4:10 PM ET
- Size
- 5.5 KB